| http://www.w3.org/ns/prov#value | - Additionally, binding agents, such as antibodies, specific for peptides encoded by the subject BRCA1 mutants are used to identify expression...http://www.google.com/patents/US5622829?utm_source=gb-gplus-sharePatent US5622829 - Genetic markers for breast, ovarian, and prostatic cancerAdvanced Patent SearchPublication numberUS5622829 APublication typeGrantApplication numberUS 08/425,061Publication d
|
